Detalhe da pesquisa
1.
Axon guidance cue SEMA3A promotes the aggressive phenotype of basal-like PDAC.
Gut
; 2024 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38670629
2.
CXCR1/2 dual-inhibitor ladarixin reduces tumour burden and promotes immunotherapy response in pancreatic cancer.
Br J Cancer
; 128(2): 331-341, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36385556
3.
Leptin-mediated meta-inflammation may provide survival benefit in patients receiving maintenance immunotherapy for extensive-stage small cell lung cancer (ES-SCLC).
Cancer Immunol Immunother
; 72(11): 3803-3812, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37668709
4.
Talniflumate abrogates mucin immune suppressive barrier improving efficacy of gemcitabine and nab-paclitaxel treatment in pancreatic cancer.
J Transl Med
; 21(1): 843, 2023 11 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37996891
5.
KRAS-Dependency in Pancreatic Ductal Adenocarcinoma: Mechanisms of Escaping in Resistance to KRAS Inhibitors and Perspectives of Therapy.
Int J Mol Sci
; 24(11)2023 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37298264
6.
Oncolytic Effect of Zika Virus in Neuroendocrine Pancreatic Tumors: New Perspectives for Therapeutic Approaches.
Int J Mol Sci
; 24(24)2023 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38139100
7.
Pathologic angiogenesis in the bone marrow of humanized sickle cell mice is reversed by blood transfusion.
Blood
; 135(23): 2071-2084, 2020 06 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31990287
8.
Minimally invasive tricuspid valve surgery without caval occlusion: Short and midterm results.
J Card Surg
; 36(2): 618-623, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33403735
9.
Intraductal Pancreatic Mucinous Neoplasms: A Tumor-Biology Based Approach for Risk Stratification.
Int J Mol Sci
; 21(17)2020 Sep 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32887490
10.
Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung Cancer.
Mediators Inflamm
; 2019: 7652014, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31827379
11.
Inflammatory profile in mitochondrial diseases: A cohort study.
Eur J Neurol
; 30(10): 3409-3410, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37402160
12.
TAK-ing aim at chemoresistance: The emerging role of MAP3K7 as a target for cancer therapy.
Drug Resist Updat
; 33-35: 36-42, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29145973
13.
Pancreatic Cancer and Obesity: Molecular Mechanisms of Cell Transformation and Chemoresistance.
Int J Mol Sci
; 19(11)2018 Oct 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-30366466
14.
Angiopoietin-Like Proteins in Angiogenesis, Inflammation and Cancer.
Int J Mol Sci
; 19(2)2018 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29389861
15.
Tissue transglutaminase (TG2) is involved in the resistance of cancer cells to the histone deacetylase (HDAC) inhibitor vorinostat.
Amino Acids
; 49(3): 517-528, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27761756
16.
Combined inhibition of IL1, CXCR1/2, and TGFß signaling pathways modulates in-vivo resistance to anti-VEGF treatment.
Anticancer Drugs
; 27(1): 29-40, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26473526
17.
The Role of the Complement in Clear Cell Renal Carcinoma (ccRCC)-What Future Prospects Are There for Its Use in Clinical Practice?
Cancers (Basel)
; 16(3)2024 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38339243
18.
Prognostic role of circulating cytokines and inflammation indexes for avelumab maintenance in metastatic urothelial carcinoma.
Front Immunol
; 15: 1401214, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38799450
19.
Cellular collusion: cracking the code of immunosuppression and chemo resistance in PDAC.
Front Immunol
; 15: 1341079, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38817612
20.
Identification of spatially-resolved markers of malignant transformation in Intraductal Papillary Mucinous Neoplasms.
Nat Commun
; 15(1): 2764, 2024 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38553466